SCHEMBL29231123

SCHEMBL29231123

Cc1ccnn1CC(=O)N1CC(F)CC1C(=O)NC(c1ccccc1)c1ccc(C(C)C)c(F)n1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CFD P00746 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26816712 1.00 CFD (0.42) CFD
SCHEMBL29231130 0.92 CFD (0.41) CFD
SCHEMBL24666203 0.92 CFD (0.41) CFD
SCHEMBL29820551 0.89 CFD (0.39) CFD
SCHEMBL26816629 0.89 CFD (0.39) CFD
SCHEMBL30341372 0.89 CFD (0.39) CFD
SCHEMBL29230861 0.89 CFD (0.39) CFD
SCHEMBL26816112 0.89 CFD (0.39) CFD
SCHEMBL29230978 0.89 CFD (0.39) CFD
SCHEMBL29230748 0.89 CFD (0.41) CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117956985-A Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof 梅兹治疗公司 2024-04-30 — — CN disclosed
EP-4308095-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2024-01-24 — — EP disclosed
WO-2022198196-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2022-09-22 — — WO disclosed
Send feedback